New Key Statistics Module, Z-Score and F-Score
TSX:SZLS Key Ratios
| Market Cap C$ M | 4.91 |
| Enterprise Value C$ M | 6.73 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.11 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) C$ M | 4.00 |
| EPS (TTM) C$ | -0.17 |
| Beneish M-Score | -48.63 |
| 10-y EBITDA Growth Rate % | 27.60 |
| 5-y EBITDA Growth Rate % | 8.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.40 |
| EV-to-EBITDA | -0.41 |
| PEG | -- |
| Shares Outstanding M | 122.72 |
| Net Margin (%) | -420.86 |
| Operating Margin % | -154.03 |
| Pre-tax Margin (%) | -420.86 |
| Quick Ratio | 0.03 |
| Current Ratio | 0.04 |
| ROA % (ttm) | -574.18 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -149.29 |
| Dividend Yield % | -- |
| Altman Z-Score | -440.58 |
TSX:SZLS Number of Guru Trades
TSX:SZLS Volume of Guru Trades
Gurus Latest Trades with TSX:SZLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:SZLS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
StageZero Life Sciences Ltd Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers